Thought Leader Relationship Management Best Practices

Key Opinion Leaders (KOLs) have proven to be among of the most effective and critical means of building product awareness in the medical and scientific communities. Indeed, KOL relationship management itself has emerged as a necessary and vital part of brand success.

This updated Best Practices, LLC research from 2012 examines how leading pharmaceutical companies approach KOL management.

This study identifies the critical success factors associated with KOL management excellence. Pharma executives can use this benchmarking research to learn best practices in KOL management and discover how they can maximize KOL relationships to benefit their own products and therapies.

Industries Profiled:
Medical Device; Medical; Pharmaceutical; Biotech; Consulting; Consumer Products; Diagnostic; Marketing; Health Care


Companies Profiled:
Becton Dickinson; ArjoHuntleigh; GlaxoSmithKline ; Medinnovation; Dendreon Corporation; Scientific Advantage; Abbott Laboratories; Galen Ltd; Shire; Stallergenes; Smith & Nephew; Santarus; Inc.; Bayer Healthcare; The Arcas Group; Teva Pharmaceutical Industries Ltd; Pierre Fabre Medicament; MSD; Janssen; Medtronic; Takeda Pharmaceuticals; Onyx Pharmaceuticals; Boston Scientific; Kadmon Pharmaceuticals; Novo Nordisk; Boehringer Ingelheim; Hospira; Pfizer; Eli Lilly

Study Snapshot

This research involved an online survey of nearly 36 respondents representing 30 different biopharmaceutical companies. More than 80 percent of participants were from Medical Affairs or Clinical Affairs departments.

Key topics include:

• KOL Relationship Management Structure and Staffing
• KOL Management Approaches and Tactics
• Evaluating KOL Relationships and Value

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.